Annual Drug Patent Expirations for AMITIZA
Amitiza is a drug marketed by Sucampo Pharma Llc and is included in one NDA. It is available from four suppliers. There are ten patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for AMITIZA.
This drug has one hundred and sixty-three patent family members in twenty-seven countries.
The generic ingredient in AMITIZA is lubiprostone. Four suppliers are listed for this compound. Additional details are available on the lubiprostone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
